GSA Capital Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Buy |
720,860
+196,184
| +37% | +$141K | 0.04% | 895 |
|
|
2025
Q1 | $771K | Buy |
524,676
+510,809
| +3,684% | +$751K | 0.07% | 507 |
|
|
2024
Q4 | $61K | Sell |
13,867
-337,326
| -96% | -$1.48M | ﹤0.01% | 1527 |
|
|
2024
Q3 | $1.45M | Buy |
351,193
+232,087
| +195% | +$956K | 0.11% | 241 |
|
|
2024
Q2 | $777K | Sell |
119,106
-57,066
| -32% | -$372K | 0.05% | 684 |
|
|
2024
Q1 | $1.53M | Buy |
+176,172
| New | +$1.53M | 0.12% | 216 |
|
|
2023
Q3 | – | Sell |
-63,606
| Closed | -$677K | – | 1698 |
|
|
2023
Q2 | $677K | Sell |
63,606
-39,652
| -38% | -$422K | 0.07% | 551 |
|
|
2023
Q1 | $1.09M | Buy |
103,258
+42,309
| +69% | +$445K | 0.11% | 273 |
|
|
2022
Q4 | $755K | Buy |
60,949
+13,007
| +27% | +$161K | 0.09% | 354 |
|
|
2022
Q3 | $497K | Buy |
47,942
+37,441
| +357% | +$388K | 0.07% | 574 |
|
|
2022
Q2 | $121K | Sell |
10,501
-71,480
| -87% | -$824K | 0.02% | 1189 |
|
|
2022
Q1 | $1.03M | Buy |
+81,981
| New | +$1.03M | 0.14% | 166 |
|
|
2020
Q4 | – | Sell |
-95,165
| Closed | -$856K | – | 1399 |
|
|
2020
Q3 | $856K | Buy |
+95,165
| New | +$856K | 0.14% | 142 |
|
|
2020
Q1 | – | Sell |
-85,714
| Closed | -$1.14M | – | 1295 |
|
|
2019
Q4 | $1.14M | Buy |
85,714
+1,627
| +2% | +$21.7K | 0.13% | 155 |
|
|
2019
Q3 | $722K | Buy |
+84,087
| New | +$722K | 0.1% | 319 |
|
|
2014
Q1 | – | Sell |
-17,748
| Closed | -$173K | – | 1672 |
|
|
2013
Q4 | $173K | Buy |
+17,748
| New | +$173K | 0.01% | 1491 |
|
|
2013
Q3 | – | Sell |
-18,625
| Closed | -$155K | – | 1601 |
|
|
2013
Q2 | $155K | Buy |
+18,625
| New | +$155K | 0.02% | 1156 |
|